CSOP Hang Seng Biotech ETF (HKG:3174)
3.282
-0.102 (-3.01%)
Last updated: Mar 4, 2026, 3:24 PM HKT
HKG:3174 Holdings Information
HKG:3174 is an equity ETF with a total of 31 individual holdings. The top holdings are WuXi Biologics stock at 12.99%, BeOne Medicines AG at 9.73%, Innovent Biologics at 9.27%, CSPC Pharmaceutical Group at 7.56%, and Akeso at 7.56%.
Total Holdings
31
Top 10 Percentage
70.65%
Asset Class
Equity
ETF Category
Health Care
Assets
886.49M
PE Ratio
29.99
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 12.99% |
| 2 | HKG: 6160 | BeOne Medicines AG | 9.73% |
| 3 | HKG: 1801 | Innovent Biologics, Inc. | 9.27% |
| 4 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 7.56% |
| 5 | HKG: 9926 | Akeso, Inc. | 7.56% |
| 6 | HKG: 1177 | Sino Biopharmaceutical Limited | 5.94% |
| 7 | HKG: 2359 | WuXi AppTec Co., Ltd. | 5.28% |
| 8 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 5.10% |
| 9 | HKG: 1530 | 3SBio Inc. | 3.93% |
| 10 | HKG: 2228 | XtalPi Holdings Limited | 3.28% |
| 11 | HKG: 6618 | JD Health International Inc. | 2.95% |
| 12 | HKG: 6990 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2.39% |
| 13 | HKG: 2268 | WuXi XDC Cayman Inc. | 2.22% |
| 14 | HKG: 0867 | China Medical System Holdings Limited | 1.86% |
| 15 | HKG: 0241 | Alibaba Health Information Technology Limited | 1.69% |
| 16 | HKG: 1548 | Genscript Biotech Corporation | 1.57% |
| 17 | HKG: 9688 | Zai Lab Limited | 1.57% |
| 18 | HKG: 3933 | The United Laboratories International Holdings Limited | 1.49% |
| 19 | HKG: 1099 | Sinopharm Group Co. Ltd. | 1.39% |
| 20 | INCPF | InnoCare Pharma Ltd | 1.35% |
| 21 | HKG: 6855 | Ascentage Pharma Group International | 1.32% |
| 22 | HKG: 0853 | MicroPort Scientific Corporation | 1.30% |
| 23 | HKG: 1066 | Shandong Weigao Group Medical Polymer Company Limited | 1.22% |
| 24 | 13.HK | HUTCHMED (China) Ltd | 1.22% |
| 25 | HKG: 2252 | Shanghai MicroPort MedBot (Group) Co., Ltd. | 1.19% |
As of Mar 2, 2026